Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Clinical trial NCT02446912 · COMPLETED
Trial details
- NCT number
- NCT02446912
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-09
- Primary completion
- 2018-07-17
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.